Published in J Allergy Clin Immunol on July 01, 2004
Omalizumab: a monoclonal anti-IgE antibody. MedGenMed (2005) 0.82
Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med (2002) 9.01
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A (2002) 5.07
Food allergy. J Allergy Clin Immunol (2009) 4.05
US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol (2010) 3.99
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41
Filaggrin mutations associated with skin and allergic diseases. N Engl J Med (2011) 3.40
Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity (2006) 3.39
Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol (2010) 3.22
Epidemiology of food allergy. J Allergy Clin Immunol (2011) 3.11
Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol (2007) 2.79
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev (2011) 2.62
Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med (2010) 2.40
Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol (2012) 2.27
Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol (2010) 2.20
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol (2009) 2.20
Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol (2004) 2.16
Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol (2006) 2.08
Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol (2003) 2.05
Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. J Allergy Clin Immunol (2004) 2.00
Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol (2009) 2.00
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants. J Allergy Clin Immunol (2010) 1.97
Prevalence of seafood allergy in the United States determined by a random telephone survey. J Allergy Clin Immunol (2004) 1.90
Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol (2006) 1.88
Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol (2007) 1.85
Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol (2005) 1.78
Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol (2010) 1.77
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol (2007) 1.77
Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med (2008) 1.68
Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol (2003) 1.66
Smallpox vaccination: Risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol (2002) 1.60
Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol (2007) 1.57
Cluster analysis of obesity and asthma phenotypes. PLoS One (2012) 1.56
IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol (2007) 1.55
Ceragenins: a class of antiviral compounds to treat orthopox infections. J Invest Dermatol (2009) 1.55
Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol (2005) 1.54
Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med (2005) 1.53
IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation. J Immunol (2010) 1.49
10. Atopic dermatitis. J Allergy Clin Immunol (2006) 1.48
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
The role of allergens in asthma. Am Fam Physician (2007) 1.47
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2007. J Allergy Clin Immunol (2008) 1.46
Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol (2008) 1.44
Vitamin D in atopic dermatitis, asthma and allergic diseases. Immunol Allergy Clin North Am (2010) 1.43
Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol (2010) 1.42
Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol (2006) 1.40
Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol (2009) 1.38
Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol (2010) 1.38
IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol (2006) 1.37
T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol (2004) 1.36
The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med (2013) 1.36
The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol (2007) 1.32
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol (2011) 1.30
Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics (2003) 1.30
Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep (2006) 1.29
Food protein-induced enterocolitis syndrome: case presentations and management lessons. J Allergy Clin Immunol (2005) 1.28
Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol (2008) 1.27
Allergic skin diseases. J Allergy Clin Immunol (2009) 1.25
Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J Allergy Clin Immunol (2010) 1.25
Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response. Proc Natl Acad Sci U S A (2009) 1.23
Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins. Biochemistry (2002) 1.23
Timing of initial exposure to cereal grains and the risk of wheat allergy. Pediatrics (2006) 1.22
Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma. J Allergy Clin Immunol (2012) 1.22
Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis (2008) 1.22
TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier. J Invest Dermatol (2011) 1.18
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol (2008) 1.17
Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol (2008) 1.15
Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol (2005) 1.14
A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J Immunol (2002) 1.13
Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol (2007) 1.13
Characterization of Staphylococcus aureus enterotoxin L. Infect Immun (2003) 1.13
Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol (2006) 1.11
Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation. J Biol Chem (2009) 1.10
Vitamin D and food allergy in patients with severe atopic dermatitis. J Allergy Clin Immunol (2013) 1.10
Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. J Allergy Clin Immunol (2006) 1.09
Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. J Allergy Clin Immunol (2011) 1.08
Renaissance of the hygiene hypothesis. J Allergy Clin Immunol (2006) 1.07
Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation. J Allergy Clin Immunol (2007) 1.05
Immunopathology of atopic dermatitis. J Allergy Clin Immunol (2006) 1.05
Role of bacterial superantigens in atopic dermatitis : implications for future therapeutic strategies. Am J Clin Dermatol (2006) 1.05
Oral food challenges in children with a diagnosis of food allergy. J Pediatr (2010) 1.03
Atopic dermatitis. J Allergy Clin Immunol (2006) 1.02
Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol (2006) 1.02
Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J Allergy Clin Immunol (2009) 1.02
Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens. J Mol Biol (2007) 1.01
Racial differences in T-lymphocyte response to glucocorticoids. Chest (2005) 1.01
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol (2011) 1.01
IFN-gamma reverses IL-2- and IL-4-mediated T-cell steroid resistance. Am J Respir Cell Mol Biol (2008) 1.00
Increased glucocorticoid receptor Beta expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype. Am J Respir Cell Mol Biol (2002) 1.00
The infectious aspects of atopic dermatitis. Immunol Allergy Clin North Am (2010) 0.98
Obesity impairs apoptotic cell clearance in asthma. J Allergy Clin Immunol (2012) 0.98
Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry (2014) 0.95
Advances in atopic dermatitis. Curr Opin Immunol (2011) 0.95
Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect Immun (2002) 0.94
Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal α-toxin-induced keratinocyte death. J Allergy Clin Immunol (2012) 0.94
Vaccinia virus-specific molecular signature in atopic dermatitis skin. J Allergy Clin Immunol (2010) 0.94
Divergent expression and function of glucocorticoid receptor beta in human monocytes and T cells. J Leukoc Biol (2006) 0.94
Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients. J Allergy Clin Immunol (2012) 0.93